Royal Bank of Canada’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.29M Buy
351,263
+349,342
+18,185% +$3.27M ﹤0.01% 2656
2025
Q1
$24K Sell
1,921
-348
-15% -$4.35K ﹤0.01% 5476
2024
Q4
$30K Sell
2,269
-7,108
-76% -$94K ﹤0.01% 5443
2024
Q3
$181K Buy
9,377
+1,162
+14% +$22.4K ﹤0.01% 4459
2024
Q2
$169K Buy
8,215
+6,229
+314% +$128K ﹤0.01% 4518
2024
Q1
$47K Sell
1,986
-17,376
-90% -$411K ﹤0.01% 5130
2023
Q4
$418K Buy
19,362
+7,883
+69% +$170K ﹤0.01% 3910
2023
Q3
$167K Buy
11,479
+4,126
+56% +$60K ﹤0.01% 4489
2023
Q2
$154K Buy
7,353
+1,202
+20% +$25.2K ﹤0.01% 4545
2023
Q1
$129K Sell
6,151
-3,327
-35% -$69.8K ﹤0.01% 4601
2022
Q4
$241K Buy
9,478
+5,856
+162% +$149K ﹤0.01% 4265
2022
Q3
$87K Buy
3,622
+3,331
+1,145% +$80K ﹤0.01% 4921
2022
Q2
$6K Sell
291
-2,725
-90% -$56.2K ﹤0.01% 6128
2022
Q1
$52K Sell
3,016
-5,715
-65% -$98.5K ﹤0.01% 5585
2021
Q4
$192K Buy
8,731
+8,276
+1,819% +$182K ﹤0.01% 4855
2021
Q3
$9K Sell
455
-2,623
-85% -$51.9K ﹤0.01% 6483
2021
Q2
$53K Buy
3,078
+548
+22% +$9.44K ﹤0.01% 5510
2021
Q1
$57K Buy
2,530
+2,259
+834% +$50.9K ﹤0.01% 5312
2020
Q4
$6K Buy
271
+235
+653% +$5.2K ﹤0.01% 6037
2020
Q3
$1K Sell
36
-1,506
-98% -$41.8K ﹤0.01% 5979
2020
Q2
$23K Sell
1,542
-69
-4% -$1.03K ﹤0.01% 5068
2020
Q1
$18K Sell
1,611
-44
-3% -$492 ﹤0.01% 5095
2019
Q4
$15K Buy
+1,655
New +$15K ﹤0.01% 5390
2018
Q4
Sell
-1,026
Closed -$8K 6086
2018
Q3
$8K Sell
1,026
-517
-34% -$4.03K ﹤0.01% 5467
2018
Q2
$11K Buy
1,543
+643
+71% +$4.58K ﹤0.01% 5211
2018
Q1
$13K Buy
900
+871
+3,003% +$12.6K ﹤0.01% 5022
2017
Q4
$0 Sell
29
-804
-97% ﹤0.01% 6004
2017
Q3
$10K Buy
833
+797
+2,214% +$9.57K ﹤0.01% 5514
2017
Q2
$1K Sell
36
-200
-85% -$5.56K ﹤0.01% 5674
2017
Q1
$3K Sell
236
-36
-13% -$458 ﹤0.01% 5674
2016
Q4
$2K Buy
+272
New +$2K ﹤0.01% 5714